Response of adenocarcinoma of the uterine cervix to chemoradiotherapy

Kaidar-Person,Orit; Yosefia,Sawsan; Abdah-Bortnyak,Roxolyana

doi:10.3892/ol.2015.3105

June-2015 Volume 9 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2015 Volume 9 Issue 6

Full Size Image

Article

Response of adenocarcinoma of the uterine cervix to chemoradiotherapy

Authors:
- Orit Kaidar-Person
- Sawsan Yosefia
- Roxolyana Abdah-Bortnyak
View Affiliations / Copyright

Affiliations: Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel
Pages: 2791-2794
|
Published online on: April 8, 2015

https://doi.org/10.3892/ol.2015.3105
Expand metrics +

Abstract

The aim of the current retrospective study was to investigate the response of advanced cervical adenocarcinoma (AC) to definitive chemoradiotherapy. Uterine cervical cancer is one of the most common cancer types among females, with squamous cell carcinoma (SQCC) being the most prevalent histological type. The incidence of cervical AC and its variants has markedly increased in recent decades. The current understanding with regard to the treatment of cervical cancer has been established through studies in which the majority of the patients suffered from SQCC, while only a limited number of studies have focused on the treatment of AC. Therefore, the optimal treatment for uterine cervical AC remains unclear. In the present study, data were collected from the medical files of patients who were diagnosed with advanced uterine cervical AC and treated with chemoradiotherapy between 1998 and 2013. Data were also collected from a group of patients with SQCC for comparison with AC patients in terms of response and survival. A total of 68 uterine cervical cancer cases were included, including 29 AC patients and 39 SQCC patients. Compared with the SQCC subgroup, a higher number of AC patients required surgery following chemoradiotherapy due to a lack of response to the initial treatment (5% vs. 31%, respectively; P=0.0065). After a median follow‑up period of 10 years, patients with AC exhibited shorter overall survival (7.4 years vs. 11 years for AC and SQCC groups, respectively; P=0.01). Differences in recurrence (40.7% vs. 34.4%; P=0.79) and disease‑free interval (1.2 years vs. 2 years; P=0.11) were not statistically significant. The results indicated that cervical AC is less responsive to chemoradiotherapy compared with SQCC.

View Figures

View References

1	Fujiwara K, Monk B and Devouassoux-Shisheboran M: Adenocarcinoma of the uterine cervix: why is it different? Curr Oncol Rep. 16:4162014. View Article : Google Scholar : PubMed/NCBI
2	Eifel PJ, Burke TW, Morris M and Smith TL: Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 59:38–44. 1995. View Article : Google Scholar : PubMed/NCBI
3	Smith HO, Tiffany MF, Qualls CR and Key CR: The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol. 78:97–105. 2000. View Article : Google Scholar : PubMed/NCBI
4	Chen JL, Huang CY, Huang YS, et al: Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy. Acta Obstet Gynecol Scand. 93:661–668. 2014. View Article : Google Scholar : PubMed/NCBI
5	Lacey JV Jr, Swanson CA, Brinton LA, et al: Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer. 98:814–821. 2003. View Article : Google Scholar : PubMed/NCBI
6	Huang YT, Wang CC, Tsai CS, et al: Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys. 84:420–427. 2012. View Article : Google Scholar : PubMed/NCBI
7	Wakatsuki M, Kato S, Ohno T, et al: Working Group of the Gynecological Tumor: Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704). Cancer. 120:1663–1669. 2014. View Article : Google Scholar : PubMed/NCBI
8	Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA and Lee HP: Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 104:95–99. 2007. View Article : Google Scholar : PubMed/NCBI
9	van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al: CROSS Group: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
10	Menkarios C, Azria D, Laliberté B, Moscardo CL, Gourgou S, Lemanski C, et al: Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol. 2:412007. View Article : Google Scholar : PubMed/NCBI
11	Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al: Alliance for Cervical Cancer Prevention Cost Working Group: Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 353:2158–2168. 2005. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Response of adenocarcinoma of the uterine cervix to chemoradiotherapy

This article is mentioned in:

Abstract

Figure 1

Related Articles